News | June 24, 2022
Merck KGaA doubles HPAPI production capacity in Wisconsin
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
The company is now introducing the product into the India pharmaceutical market.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
The production suspension impacts commercial and clinical trial supply
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The plant is expected to start commercial operations from Q4FY24
All the capex is being met through internal accruals only
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
The new facility is scheduled to start operation in the first half of 2024
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
Subscribe To Our Newsletter & Stay Updated
